Indication
Non-24-Hour Sleep-Wake Disorder
The Non-24-Hour Sleep-Wake Disorder pipeline: 1 tracked drug, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Non-24-Hour Sleep-Wake Disorder, so this list is not complete.
1 approved / phase 4
Market size not yet sourced. How markets are sized ↗